NOBIVAC® CANINE 1-PV
A modified live vaccine for the immunisation of healthy dogs against canine parvovirus.
FOR ANIMAL USE ONLY
NOBIVAC® CANINE 1-PV
Reg. No. G3894 (Act 36/1947)
Namibia Reg. No. V04/24.1/906 [NS2]
This vaccine may only be used by or under the supervision of persons registered in terms of or authorised in terms of section 23 (1) (c) of the Veterinary and Para-Veterinary Professions Act, 1982 (Act No. 19 of 1982).
INDICATIONS
A modified live vaccine for the immunisation of healthy dogs against canine parvovirus.
COMPOSITION
Modified live vaccine containing canine parvovirus type 2b strain.
Maximum moisture content at release: ≤ 5,5 %.
Contains gentamicin and thimerosal as preservatives.
STORAGE
- Store between 2 °C en 8 °C.
- Do not freeze.
- Protect from light.
WARNINGS
- DO NOT VACCINATE PREGNANT BITCHES.
- Vaccinate only healthy, non-parasitised dogs.
- Dispose of any unused vaccine as well as all empty vaccine containers and vaccination equipment according to local waste disposal regulations.
- KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
- Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.
PRECAUTIONS
- Use new, non-chemically sterilised needles and syringes.
- Do not mix with other vaccines.
- Anaphylactic or hypersensitivity reactions may occur.
Antidote: Adrenaline, corticosteroids and antihistamines may all be indicated depending on the nature and severity of the reaction.
DIRECTIONS FOR USE – USE ONLY AS DIRECTED
Inject 1 mℓ Nobivac® Canine 1-Pv subcutaneously or intramuscularly at 6 weeks of age or older.
- Repeat dose at 2 to 4 week intervals until the dog is 12 weeks of age.
- A minimum of two 1 mℓ doses are required for primary immunisation.
- Although duration of immunity is at least 4 years for parvovirus, annual revaccination with one dose might be considered necessary if the individual risk profile or immune status so determines.
PRESENTATION
25 x 1 dose (1 mℓ) vials per poly vinyl chloride (PVC) tray.
Carton must be sold as a unit. Do not break seal or open before sale.
REGISTRATION HOLDER
Intervet South Africa (Pty) Ltd.
20 Spartan Road, Spartan,
1619, RSA
Tel: +27 (0) 11 923 9300
Fax: +27 (0) 11 392 3158
www.msd-animal-health.co.za
DATE OF PUBLICATION OF THIS PACKAGE INSERT
14 December 2010